• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Atrial fibrillation (AF) and chronic kidney disease (CKD) often coexist as they share multiple
risk factors, including hypertension, diabetes mellitus, and coronary artery disease. Although …

Atrial fibrillation (AF) and venous thromboembolism (VTE) are highly prevalent conditions
with a significant healthcare burden, and represent the main indications for anticoagulation …

The population with concomitant heart and kidney disease (often termed
'cardiorenal'disease) is expected to grow, significantly impacting public health and …

Objective To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …

Objective To determine the association of chronic kidney disease (CKD) with the safety and
efficacy of IV thrombolysis (IVT) among patients with acute ischemic stroke (AIS). Methods A …

The optimal approach to prevent stroke and systemic embolism in patients with advanced
chronic kidney disease (CKD) and atrial fibrillation remains unresolved. We conducted a …

Background: The current systematic review aimed to compare bleeding outcomes in dental
extraction patients receiving uninterrupted Direct-acting oral anticoagulant (DOAC) or …

Intravascular thrombus formation and embolization are among the most frequent events
leading to a number of cardiovascular conditions with high morbidity and mortality. The …

Direct oral anticoagulants in chronic kidney disease: an upd... : Current Opinion in Nephrology
and Hypertension Direct oral anticoagulants in chronic kidney disease: an update : Current …